Myofascial Release in Patients with Chronic Obstructive Pulmonary Disease

NCT ID: NCT04260243

Last Updated: 2025-02-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2026-03-31

Study Completion Date

2027-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main objective of this study is to assess the effects of a myofascial release protocol in patients with chronic obstructive pulmonary disease (COPD).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

So far, there are no previous studies that analyze the effects of a myofascial relaxation protocol applied to the diaphragm within the respiratory rehabilitation treatment in patients with chronic obstructive pulmonary disease.

Aim: The main objective of this study is to assess the effects of a 3 weeks myofascial release protocol applied to the diaphragm on respiratory parameters in patients with chronic obstructive pulmonary disease.

Design: Randomized clinical trial

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Copd

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Sham Myofascial + Respiratory rehabilitation

Respiratory rehabilitation programme + sham Myofascial Release

Group Type SHAM_COMPARATOR

Sham Myofascial + Respiratory rehabilitation

Intervention Type OTHER

6 sessions of: Sham Myofascial Release (20 minutes each) + Respiratory rehabilitation (60 minutes each)

Experimental-Myofascial + Respiratory rehabilitation

Respiratory rehabilitation programme + Myofascial Release

Group Type EXPERIMENTAL

Experimental-Myofascial + Respiratory rehabilitation

Intervention Type OTHER

6 sessions of: Myofascial Release (20 minutes each) + Respiratory rehabilitation (60 minutes each)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Experimental-Myofascial + Respiratory rehabilitation

6 sessions of: Myofascial Release (20 minutes each) + Respiratory rehabilitation (60 minutes each)

Intervention Type OTHER

Sham Myofascial + Respiratory rehabilitation

6 sessions of: Sham Myofascial Release (20 minutes each) + Respiratory rehabilitation (60 minutes each)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* COPD;
* Forced expiratory volume in the first second (FEV1) \< 80%;
* FEV1/Forced vital capacity (FVC) \< 70%;
* Maximal inspiratory pressure (MIP) \< 70%.

Exclusion Criteria

* Recent (6 months) spine or abdominal surgery;
* Allergic status of any kind;
* systemic diseases (rheumatic, infectious conditions, febrile state, vascular alterations, endocrine diseases including diabetes, metabolic, and neoplastic syndromes);
* neuromuscular or neurological injuries;
* previous myofascial release treatment.
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cardenal Herrera University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

ARGUISUELAS MARTINEZ MARÍA DOLORES

Head of Physiotherapy

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

JUAN FRANCISCO L PÁRRAGA

Role: STUDY_CHAIR

Cardenal Herrera University

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

MARÍA DOLORES ARGUISUELAS, PhD

Role: CONTACT

961369000 ext. 64352

JUAN FRANCISCO L PÁRRAGA, PhD

Role: CONTACT

618055092

References

Explore related publications, articles, or registry entries linked to this study.

Rocha T, Souza H, Brandao DC, Rattes C, Ribeiro L, Campos SL, Aliverti A, de Andrade AD. The Manual Diaphragm Release Technique improves diaphragmatic mobility, inspiratory capacity and exercise capacity in people with chronic obstructive pulmonary disease: a randomised trial. J Physiother. 2015 Oct;61(4):182-9. doi: 10.1016/j.jphys.2015.08.009. Epub 2015 Sep 19.

Reference Type BACKGROUND
PMID: 26386894 (View on PubMed)

Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM, Frith P, Halpin DM, Lopez Varela MV, Nishimura M, Roche N, Rodriguez-Roisin R, Sin DD, Singh D, Stockley R, Vestbo J, Wedzicha JA, Agusti A. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary. Arch Bronconeumol. 2017 Mar;53(3):128-149. doi: 10.1016/j.arbres.2017.02.001. Epub 2017 Mar 6. English, Spanish.

Reference Type BACKGROUND
PMID: 28274597 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UNIVERSITY CARDENAL HERRERA-23

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.